← Industry Guides
HealthcareCRA Guide

EU Cyber Resilience Act Guide for Electronic Health Record & Clinical IT Vendors

Important — Class I (most EHR platforms); Class II if integrated with clinical decision support affecting direct treatment

Electronic health record (EHR) and clinical IT vendors selling software to EU healthcare providers face obligations under both the CRA and the emerging European Health Data Space (EHDS) regulation. EHR systems are critical healthcare infrastructure — their compromise directly affects patient safety, treatment continuity, and the confidentiality of some of the most sensitive personal data categories under GDPR. Ransomware attacks on hospital EHR systems have repeatedly caused patient harm through care disruption, making CRA compliance an urgent clinical safety matter as well as a regulatory obligation.

Article 13Article 14Annex IAnnex IIIArticle 10Article 11Article 6
Deadline: September 2026Classification: Important — Class I (most EHR platforms); Class II if integrated with clinical decision support affecting direct treatment

CRA Scope and EHDS Interaction for Clinical IT

EHR platforms, clinical decision support systems (CDSS), patient administration systems (PAS), radiology information systems (RIS), laboratory information systems (LIS), and picture archiving and communication systems (PACS) sold to EU healthcare providers are products with digital elements under Article 3(1). The European Health Data Space (EHDS) Regulation, which entered into force in 2024, creates additional obligations for EHR system vendors including interoperability, data portability, and security requirements for health data sharing. CRA and EHDS compliance obligations must be managed in parallel. EHR systems that include clinical decision support functions directly influencing prescribing or treatment decisions are strong candidates for Important Products Class II under Annex III, given the direct patient safety implications of system compromise or manipulation. Standard EHR platforms without AI-driven decision support are likely Class I.

CRA reference:Article 3(1), Annex III

Technical Security for EHR and Clinical Systems

EHR and clinical systems are among the most actively targeted products in the cybersecurity threat landscape, with healthcare providers consistently appearing in the top sectors affected by ransomware. Annex I security requirements for clinical IT vendors include: implementing multi-factor authentication for all clinical user access, not solely administrators; encrypting all patient data at rest and in transit, including database-level encryption and TLS for all API and integration communications; providing role-based access control granular enough to enforce clinical access boundaries (e.g. mental health records access separation); implementing tamper-evident audit logging of all patient record access, modification, and disclosure events; ensuring backup and recovery mechanisms are sufficient to restore clinical operations within clinically safe timeframes following an attack; eliminating default shared accounts for system interfaces and integration engines; and maintaining comprehensive SBOMs covering all application components, integration middleware, and database engines.

CRA reference:Annex I Parts I and II

CVD Policy Under Article 13 for Healthcare IT Vendors

Article 13 requires a published CVD policy. For EHR vendors, the CVD programme must operate within the healthcare sector's unique regulatory environment: vulnerabilities in EHR systems are sensitive because disclosure details could enable targeted attacks on healthcare infrastructure. The CVD policy must specify: a dedicated security reporting channel with defined response timelines; coordination procedures with national health sector CSIRTs (e.g. NHS Digital's cyber operations in comparable contexts, or national health ministry cybersecurity teams in EU member states); a process for communicating security patches to healthcare provider customers in a manner compatible with hospital change management and IT governance processes; and interim mitigation guidance for vulnerabilities in clinical systems where immediate patching would require system downtime during clinical hours. ENISA's health sector cybersecurity guidelines provide supplementary guidance applicable to CVD programme design for clinical IT vendors.

CRA reference:Article 13(6), Article 13(7)

Article 14 Reporting for Clinical IT Incidents

Article 14 requires CSIRT notification within 24 hours of confirmed active exploitation. For EHR vendors, active exploitation — ransomware deployment, data exfiltration, or system manipulation — simultaneously requires: CRA CSIRT notification (within 24 hours); GDPR special category data breach notification to the relevant data protection authority (within 72 hours); and potentially notification to national health authority or competent authority if patient safety is affected. Healthcare providers affected by an EHR compromise will have their own NIS2 incident reporting obligations — vendor notifications must be rapid and detailed enough to support the provider's regulatory response. Pre-established incident response playbooks that address all parallel notification obligations — with pre-written templates and authorised decision-makers identified — are essential for meeting the 24-hour CRA notification requirement while managing the clinical and regulatory complexity of a healthcare IT incident.

CRA reference:Article 14(1), Article 14(2), Article 14(3)

Conformity Assessment and Healthcare Procurement

Class I EHR systems may self-declare CRA conformity. Given that healthcare providers are NIS2-regulated essential entities, CRA CE marking and robust security documentation will become standard procurement requirements for EHR tenders across EU member states. The technical file must include: complete security architecture documentation including all external integration interfaces; threat model addressing ransomware, insider threat, and supply chain attack scenarios specifically relevant to healthcare; SBOM; evidence of regular penetration testing; CVD policy; and the declaration of conformity. ISO 27001 certification and SOC 2 Type II reports provide supporting evidence but do not substitute for CRA-specific documentation. For Class II clinical decision support products, notified body assessment is required. Healthcare provider procurement teams are among the most security-literate in any sector following repeated high-profile ransomware incidents — vendors who cannot demonstrate mature CRA compliance will face competitive disadvantage in tenders.

CRA reference:Article 24, Article 28, Annex VIII

EHDS Interoperability and Security Requirements

The EHDS Regulation requires EHR systems to support health data sharing across EU member states using standardised formats (HL7 FHIR) and to implement security controls appropriate for cross-border health data exchange. CRA security requirements for APIs and data sharing interfaces are closely aligned with EHDS security requirements for health data access services. Vendors should design their EHDS-compliant API architecture to simultaneously satisfy CRA Annex I interface security requirements — authenticated, encrypted, rate-limited APIs with comprehensive access logging. The EHDS MyHealth@EU infrastructure imposes specific security requirements for national contact points, which EHR vendors connecting to this infrastructure must meet. Early engagement with your national eHealth authority on EHDS technical specifications will clarify the security requirements for EHDS-connected EHR products.

CRA reference:Annex I Part I

CVD Portal handles your CRA Article 13 obligations automatically.

Public CVD submission portal, 48-hour acknowledgment tracking, Article 14 deadline alerts, and CSAF advisory generation. Free forever for Electronic Health Record & Clinical IT Vendors.

Start your free portal

Frequently asked

We are a hospital EHR vendor deploying exclusively on customer-managed on-premises infrastructure. Are we still in scope?+

Yes. The CRA applies to software products placed on the EU market regardless of whether they are cloud-hosted or deployed on customer premises. As the software vendor, you are the manufacturer responsible for Annex I security requirements, CVD policy, and Article 14 notification for your EHR software product. The healthcare provider who deploys your software is responsible for their own deployment security — configuring the environment, managing access, applying patches — but this does not reduce your obligations as the product manufacturer. Your CRA technical file must document the security requirements and assumptions for the deployment environment, including minimum OS versions, network security requirements, and backup requirements, as part of the product documentation.

Hospitals need to apply patches through change management processes that can take 4–12 weeks. How do we meet the 'without undue delay' update requirement?+

Your obligation as the manufacturer is to make security updates available without undue delay after vulnerabilities are identified — the hospital's obligation to install updates within their change management process is separate. For critical security patches, provide hospitals with: an emergency patch procedure that can compress the change management timeline with vendor support; interim mitigations (configuration changes, network controls) that reduce risk while the formal change control process completes; a clear CVSS-based severity assessment to justify change management priority; and concise test scripts for post-patch validation. Document in your CVD policy the distinction between the patch availability date and the customer installation timeline. Healthcare providers with NIS2 obligations must apply critical patches within reasonable timeframes — your documentation supports their compliance.

How does the AI Act interact with our EHR system if we include AI-powered clinical decision support?+

AI-powered clinical decision support that influences diagnosis or treatment recommendations is likely a high-risk AI system under Annex III of the EU AI Act (medical devices, critical health infrastructure). High-risk AI systems require conformity assessment under the AI Act in addition to CRA and any applicable MDR obligations. The AI Act imposes requirements for technical robustness, accuracy, data governance, transparency, and human oversight specifically for high-risk AI systems. CRA requirements apply to the underlying software product; AI Act requirements apply to the AI component specifically. Vendors should conduct AI Act classification for each CDSS feature and assess conformity pathways accordingly — the two frameworks must be managed in parallel, with a coordinated technical file approach where systems are subject to both.

Need a CVD policy template for Electronic Health Record & Clinical IT Vendors?

Download a free CRA-compliant vulnerability disclosure policy and deploy it in minutes.

Browse templates →